PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.75%
Negative net income growth while MCHP stands at 1.87%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
1.39%
Less D&A growth vs. MCHP's 3.42%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
96.10%
Well above MCHP's 92.81% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-318.88%
Negative yoy working capital usage while MCHP is 5.01%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-48.15%
Negative yoy inventory while MCHP is 112.73%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-314.61%
Negative yoy usage while MCHP is 2.70%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
91.48%
Some yoy increase while MCHP is negative at -52.12%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-34.44%
Negative yoy CFO while MCHP is 13.60%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
16.36%
Lower CapEx growth vs. MCHP's 50.28%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
33.62%
Some yoy expansion while MCHP is negative at -186.63%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-33.09%
We reduce yoy sales while MCHP is 24.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-85.71%
We reduce yoy other investing while MCHP is 223.04%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-251.72%
Both yoy lines negative, with MCHP at -617.84%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
201.96%
We slightly raise equity while MCHP is negative at -45.81%. John Neff sees competitor possibly preserving share count or buying back shares.
24.16%
Buyback growth of 24.16% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.